| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -145,287 | -127,030 | -60,616 | -137,830 |
| Depreciation and amortization | 29,191 | 17,465 | 8,707 | 24,516 |
| Stock-based compensation expense | 52,894 | 37,167 | 19,234 | 39,944 |
| Loss (gain) on disposal of assets | -2,356 | -1,503 | -13 | 2,356 |
| Loss on extinguishment of long-term debt | 0 | 0 | 0 | -1,330 |
| Amortization of debt issuance costs and discount | 2,551 | 1,691 | 831 | 2,272 |
| Noncash lease expense | 5,975 | 3,565 | 1,519 | 4,437 |
| Change in the fair value of contingent consideration | 0 | 0 | 0 | -218 |
| Accretion of marketable securities purchased at a discount | 1,599 | 1,099 | 561 | 2,272 |
| Deferred income taxes | -33,049 | 1,454 | -585 | 2,310 |
| Accounts receivable, net | 19,442 | 25,317 | 2,974 | -12,928 |
| Contract assets | -12,608 | -11,193 | -2,165 | 36,510 |
| Inventories | 25,567 | 11,513 | 6,308 | 7,118 |
| Prepaids and other current assets | 17,455 | 18,037 | 9,617 | -1,951 |
| Other non-current assets | -10,132 | -11,879 | -1,571 | -544 |
| Trade payables | -1,634 | 11,149 | 9,779 | 13,853 |
| Accrued expenses | 2,671 | 4,024 | -2,712 | 2,980 |
| Employee benefits payables | 43,417 | 3,289 | -253 | 3,525 |
| Contract liabilities | -9,187 | 7,217 | -9,294 | 27,791 |
| Other current liabilities | -1,358 | 98 | -3,699 | 4,088 |
| Non-current lease liabilities | -8,269 | -6,547 | -1,670 | -4,321 |
| Other non-current liabilities | 62 | 382 | 245 | 1,653 |
| Net cash used in operating activities | -100,990 | -77,467 | -54,225 | -46,503 |
| Purchases of property, equipment and software | 106,631 | 60,719 | 28,677 | 45,539 |
| Proceeds on disposal of assets, net | 397 | 144 | 16 | 11,756 |
| Cash paid for business combination, net of acquired cash | 132,441 | - | - | 0 |
| Purchases of marketable securities | 187,780 | 128,325 | 84,639 | 149,548 |
| Maturities of marketable securities | 179,822 | 149,495 | 84,699 | 102,930 |
| Sale of marketable securities | 3,383 | 3,383 | - | - |
| Net cash used in investing activities | -243,250 | -36,022 | -28,601 | -80,401 |
| Proceeds from atm equity offerings | 865,453 | 396,647 | 92,806 | - |
| Issuance costs related to atm equity offerings | 20,134 | 9,496 | 2,088 | - |
| Proceeds from the exercise of stock options | 2,539 | 379 | 48 | 2,074 |
| Proceeds from employee stock purchase plan | 7,751 | 4,836 | 2,237 | 4,098 |
| Proceeds from sale of employees restricted stock units to cover taxes | 80,659 | 40,715 | 17,310 | 14,991 |
| Minimum tax withholding paid on behalf of employees for restricted stock units | 65,672 | 40,421 | 16,577 | 15,169 |
| Payment of contingent consideration | - | - | - | 0 |
| Purchase of capped calls related to issuance of convertible senior notes | 0 | 0 | 0 | 43,168 |
| Proceeds from issuance of convertible senior notes | 0 | 0 | 0 | 355,000 |
| Proceeds from secured term loans | 26,716 | 25,000 | 25,000 | - |
| Repayments on secured term loan | 15,103 | 11,208 | 2,894 | 48,853 |
| Payment of debt issuance costs | 278 | 278 | 278 | 12,205 |
| Finance lease principal payments | 197 | 126 | 61 | 269 |
| Net cash provided by financing activities | 881,734 | 406,048 | 115,503 | 256,499 |
| Effect of exchange rate changes on cash and cash equivalents | -86 | 1,127 | 272 | 763 |
| Net increase in cash and cash equivalents and restricted cash | 537,408 | 293,686 | 32,949 | 130,358 |
| Cash and cash equivalents at beginning of period | 275,302 | 275,302 | 275,302 | 166,434 |
| Cash and cash equivalents at end of period | 812,710 | 568,988 | 308,251 | 296,792 |
Rocket Lab Corp (RKLB)
Rocket Lab Corp (RKLB)